This report contains recommendations for the use of ARV drugs in pregnant women for their own health and for preventing HIV infection in infants and young children, and a summary of the scientific rationale for the recommendations.
This document provides the full list of updated HIV and infant feeding recommendations, and an explanation of key points. This information is aimed at programme managers and decision makers, and those who will be in charge of revising national guidelines on prevention of vertical transmission and infant and young child feeding.
This report provides a framework for concerted partnerships and guidance to countries on specific actions to take to accelerate the scale-up of prevention of vertical transmission. The implementation of actions recommended by this guidance aims to reinforce some recent encouraging trends in the coverage of national programmes.
A new guidelines include ART for HIV+ pregnant mothers, preventing HIV infection in infants during pregnancy and labor, and treatment of the infant born to an HIV+ mother who received no treatment during pregnancy and labor.
This report reviews advances made over the past year in four areas where HIV and AIDS affect children. It finds that most countries have made important gains in preventing mother-to-child transmission of HIV and in pediatric treatment. The report also explains the need for improved norms, standards and guidelines to ensure effective implementation of programmes.
A comprehensive list of latest developments in the area of HIV/AIDS, Family planning and Reproductive Health.
A new study conducted in Kenya suggests that a widely used prophylactic antiretroviral regimen, AZT (zidovudine, Retrovir) plus a single dose of nevirapine (Viramune), may be more likely to cause nevirapine resistance than a three-drug regimen being evaluated for its potential to reduce HIV transmission during breastfeeding.
‘The United Kingdom is committed to working with others to intensify international efforts to increase to 80% by 2010 the percentage of HIV-positive pregnant women who receive anti-retroviral treatments (ARVs) to reduce the risk of mother to child transmission, both in low income and high prevalence countries.’
‘The Board requests the Secretariat to prepare options for the Portfolio and Implementation Committee to use available mechanisms to accelerate transitions to more efficacious ARV regimens for effective PMTCT strategies, which should be reported to the Board at its Twentieth Board meeting.’
‘I propose that we come together around an all-out effort to virtually eliminate mother-to-child transmission of HIV by the year 2015.’
‘We call upon other governments, development partners, civil society and private sector to join this Call to Action, and move swiftly towards supporting the measures needed to eliminate HIV in infants and young children and clear the way for a worldwide HIV-free and AIDS-free generation.’